Skip to main content
Facebook
Twitter
Linkedin
Menu
Main navigation
Home
Journal
Current Issue
Archive
Subscribe
Begin Print Subscription
Renew Print Subscription
For Authors
Author Guidelines
Submit a Manuscript
For Advertisers
About the Journal
Editorial Information
Editorial Advisory Board
Journal Staff
Contact
Topics
Latest News
Research & Insight
Columns
Interviews
Centers of Excellence
Multiple Myeloma
Conference Coverage
Special Reports
FDA Approvals
Guidelines Updates
Health Economics and Outcomes Research
Policy Updates
Precision Medicine
Real-World Outcomes
Value-Based Care
Treatment Areas
Autoimmune Diseases
Blood Cancer
Breast Cancer
CAR-T Therapies
Cardiovascular Diseases
Colorectal Cancer
Diabetes
Gastrointestinal Cancer
Head & Neck Cancer
Hematologic Malignancies
Immuno-Oncology
Leukemia & Lymphoma
Lung Cancer
Multiple Myeloma
Non-Small Cell Lung Cancer
Ovarian Cancer
Prostate Cancer
Sarcoma
Supportive Care
Multimedia
Interactive Feature: Multiple Myeloma
Podcasts
Slideshows
Videos
CME
NACCME CME
Partner CME
Meeting
Login
Subscription
E-Newsletter
Quiz
A recently developed model for AML accurately predicts which outcome after treatment?
Mortality
Progression-Free Survival
Toxicity
Rate of Response
Current Issue
April 2018
Visit The Issue Archive >
Latest News
April 20, 2018
Challenges of PARP Inhibitor Selection and HRD Testing in Ovarian Cancer
April 20, 2018
NCI Funding for Gynecologic Cancers
April 19, 2018
Male BRCA carriers at increased risk of many cancers
E-News
Get the lastest JCP updates straight to your email!
Sign up!
